Abstract
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have